The Bbling-Free Trial Is Complete

Yes, sample size is definitely an issue. We are aware that we randomize only 600 patients. You mentioned that if these are the results and we want to find something significant, we have to go up to 7,000. And yes, we calculated 7,650. The question would be, is it worth doing it? But as you mentioned, the bling-free has just been completed. So we are in touch with the authors of the bled-free trial that is around 8,000 patients. About those, we were not 100% clear. Even during the first day, patients received the same dose,. which is one gram ballous in both groups. On the topic